Vicky Neale and David Spiegelhalter explore the role of statisticians in communicating risk to the public, and how patients can be empowered to engage with clinicians when weighing up the benefits and risks of treatment.
In the second episode of the series, Vicky talks to Professor Sir David Spiegelhalter, Chair of the Winton Centre for Risk and Evidence Communication at the University of Cambridge. A leading statistician, and author, Professor Spiegelhalter discusses his work on the successful Predict tools for breast and prostate cancer, which help patients make informed decisions about their cancer treatment.
Vicky and Professor Spiegelhalter explore the role of statisticians in communicating risk to the public, and how patients can be empowered to engage with clinicians in a meaningful way when weighing up the benefits and risks of treatment. Here, they also talk about the human side of cancer, and the care that is needed when communicating cancer risks.
